Frizzled Homolog 2 (FZD2) Antibody

Este producto es parte de FZD - Frizzled Homolog
Product Graph
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Frizzled Homolog 2 (FZD2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx214482
tested applications
ELISA, IHC

Description

FZD2 Antibody is a Rabbit Polyclonal against FZD2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Frizzled Homolog 2 (FZD2)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
ELISA: 1/1000 - 1/5000, IHC: 1/25 - 1/100. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q14332
Gene ID
2535
Alias
FDZ2,Fz2,Frizzled-2,frizzled family receptor 2,Fzd10,Fz10,fz-2,fzE2,hFz2,OMOD2
Background
Antibody anti-FZD2
Status
RUO

Descripción

FZD2 is a G protein-coupled receptor that binds Wnt ligands, mediating both canonical (β-catenin-dependent) and non-canonical (PCP and calcium) Wnt signaling pathways. It is expressed in various tissues, including the heart, lung, and skeletal system, where it regulates embryonic development, tissue remodeling, and cellular signaling. FZD2 plays a critical role in cell migration and polarity during embryogenesis, particularly in neural tube closure, heart development, and limb patterning. In cancer, FZD2 is upregulated in tumors such as gastric, liver, and lung cancers, where it enhances epithelial-mesenchymal transition (EMT), cell invasion, and metastasis through Wnt/β-catenin-independent pathways. FZD2 has also been implicated in fibrosis, including pulmonary and hepatic fibrosis, where its activation drives myofibroblast differentiation and excessive extracellular matrix production. Dysregulation of FZD2 signaling contributes to developmental abnormalities and chronic diseases. Pharmacological targeting of FZD2 offers therapeutic potential in cancer and fibrotic diseases by inhibiting aberrant Wnt signaling and EMT processes. Its role in cellular polarity and migration underscores its importance in both normal development and disease progression.

Related Products

FNab03220

FZD2 antibody

Ver Producto
abx015246

Frizzled Homolog 2 (FZD2) Antibody

Rabbit polyclonal antibody against FZD2 protein. Immunogen region is Internal.

Ver Producto
abx122578

Frizzled Homolog 2 (FZD2) Antibody

Rabbit Polyclonal against the FZD2 protein.

Ver Producto